Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Beta Bionics, Inc. (BBNX : NSDQ)

• Company Description    Beta Bionics Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of solutions. Beta Bionics Inc. is based in IRVINE, Calif. Number of Employees: 294

• Price / Volume Information    Yesterday's Closing Price: $26.51 Daily Weekly Monthly 20 Day Moving Average: 752,106 shares Shares Outstanding: 44.03 (millions) Market Capitalization: $1,167.09 (millions) Beta: 52 Week High: $30.47 52 Week Low: $8.89 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 19.79% 19.04% 12 Week 75.56% 67.05% Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 11 HUGHES - IRVINE,CA 92618 USA ph: 949-427-7785 fax: - ir@betabionics.com http://www.betabionics.com

• General Corporate Information    Officers Sean Saint - Chief Executive Officer;President and Director Adam Lezack - Chairperson of the Board of Directors Stephen Feider - Chief Financial Officer Sean Carney - Director Dan Dearen - Director Peer Information Beta Bionics, Inc. (ABMD) Beta Bionics, Inc. (DMDS) Beta Bionics, Inc. (CPWY.) Beta Bionics, Inc. (EQUR) Beta Bionics, Inc. (ECIA) Beta Bionics, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 08659B102 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/24/26 Share - Related Items Shares Outstanding: 44.03 Most Recent Split Date: (:1) Beta: Market Capitalization: $1,167.09 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.41 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.58 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/24/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.96 Price/Cash Flow: - Price / Sales: 13.18 EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: 15.38% Sales Growth vs. Year Ago Period: 63.14% vs. Previous Quarter: 17.28% ROE 09/30/25 - -35.72 06/30/25 - -59.34 03/31/25 - -307.00 ROA 09/30/25 - -20.69 06/30/25 - -26.86 03/31/25 - -43.06 Current Ratio 09/30/25 - 10.64 06/30/25 - 14.68 03/31/25 - 15.88 Quick Ratio 09/30/25 - 9.83 06/30/25 - 13.79 03/31/25 - 14.93 Operating Margin 09/30/25 - -67.03 06/30/25 - -70.36 03/31/25 - -75.17 Net Margin 09/30/25 - -87.89 06/30/25 - -94.04 03/31/25 - -101.62 Pre-Tax Margin 09/30/25 - -87.89 06/30/25 - -94.04 03/31/25 - -101.62 Book Value 09/30/25 - 6.70 06/30/25 - 6.94 03/31/25 - 7.24 Inventory Turnover 09/30/25 - 2.41 06/30/25 - 3.10 03/31/25 - 4.43 Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©